Copart (NASDAQ:CPRT) had its price target hoisted by Truist from $145.00 to $160.00 in a research report sent to investors on Friday, The Fly reports. The brokerage currently has a buy rating on the business services provider's stock.
Several other research firms have also issued reports
GameStop (NYSE:GME) stock is up some 950% year to date, eclipsing the already healthy gains in the broader stock market. However, the recent success of its shares may not necessarily mean this video game retailer can create fortunes for new investors. Let's take a closer look to see what m
Gold prices steadied on Monday after hitting their highest in five weeks as the market weighed an easing of global trade tensions against support from tempered expectations of U.S. interest rate increases.
Spot gold was mostly flat at $1,346,20 per ounce by 1030 GMT, after hitting its loftiest since Feb. 19 at $1,350.76.
U.S. gold futures for April delivery shed 0.3 percent to $1,346.30 per ounce.
The United States and South Korea agreed to revise a trade pact criticised by U.S. President Donald Trump, Seoul said, with U.S. automakers winning improved market access and Korean....More>>>
Billionaire investor Warren Buffett has plenty of reasons to celebrate after Apple’s (AAPL) incredible top and bottom line beat for its fiscal third quarter — several billion, in fact.
The Berkshire Hathaway (BRK.A) CEO, 86, famously avoided tech stocks for decades, saying, “If there’s lots of technology, we won’t understand it.” However, Berkshire started buying shares of Apple in mid-2016 and ended the year with about 59 million shares in the tech company. In January, Berkshire nearly....More>>>
“Formula for success: rise early, work hard, strike oil” – J. Paul Getty
I must confess to feeling kind of lonely at times this year being one of a handful of observers of the casino space, (and at times, the only one,) standing firm on my undiminished faith that Las Vegas Sands (NYSE:LVS) valuations were dead wrong. Now, after the Macau Parisian has opened and LVS Q3 results knocked it out of the park I suddenly have lots of company. I’m bemused to see the bandwagon suddenly getting rather crowded.
There’s no room for gloat or vapid vainglory in my....More>>>
U.S. equities fell again on Tuesday, pushing the stocks down in what was first back-to-back decline since January. Small-cap stocks were hit even harder, down for four straight sessions and in eight of the last ten sessions. The tape was heavy as political risk continues to grow amid partisan rancor in Washington.
In the end, the Dow Jones Industrial Average gave back 0.1%, the S&P 500 lost 0.3%, the Nasdaq Composite dropped 0.3% and the Russell 2000 lost 0.7%. Treasury bonds were weaker, the dollar ended higher, gold moved down the sixth consecutive session and oil fell 0.1%.
North Korea’s secret weapon is not man-made, but made of men.
It’s an army of hackers, to be precise – known collectively as “Hidden Cobra.”
In June, the U.S. Department of Homeland Security published a warning about the group and noted that Hidden Cobra was referred to by some researchers as “Lazarus,” reported NBC News on Aug. 15. For eight years now, Hidden Cobra has been stealing money from banks online – upwards of $600 billion in total worldwide.
Those funds prop up the regime’s nuclear ambitions – especially....More>>>
Shares of Switch, Inc. (NYSE:SWCH) have been given a consensus recommendation of "Buy" by the twelve research firms that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation, nine have given a buy recommendation and on
We're entering the home stretch of the year. Last month, I pointed out that the fall season is one of the best times for dividend hikes. And it will be interesting to see which companies announce dividend hikes in this challenging environment.
HOOKIPA (HOOK Quick QuoteHOOK ) announced that it has entered into a clinical collaboration and supply agreement with Merck (MRK Quick QuoteMRK ) to evaluate the former’s novel arenaviral program, HB-200, in combination with the latter’s PD-L1 inhibitor Keytruda as a fi
It's always interesting to see what billionaire investors are doing with their money. Sure, you can't match their gains simply by copying every single one of their stock picks, but it can still be helpful (and fru